The medication assessment tool for cancer pain management (MAT-CP) measures the quality of medication use in relation to guidelines. The original MAT-CP was reviewed, modified and tested at a comprehensive cancer center in Jordan. The tool comprised 30 criteria covering six different aspects of pain management. Seventy patients were included, males 41 (59%), females 29 (41%), mean age 49 (range, 20-79) years. The overall level of adherence to guidelines was 78% with good inter-rater reliability (kappa= 0.899). The tool's implementation showed opportunities for improvement in pain management at our institution. The MAT-CP was revised and validated for the first time outside Europe. This tool can be routinely used to assess and compare the qu...
Cathy L Carlson School of Nursing, Northern Illinois University, DeKalb, IL, USA Abstract: Inadequa...
Item does not contain fulltextPURPOSE: Pain is a major problem in all cancer stages. Cancer pain gui...
Most patients with advanced or metastatic cancer experience pain and despite several guidelines, und...
The medication assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring qua...
A clinical tool to examine prescribing in cancer pain management may provide a means to help establi...
The medication-assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring the...
Cancer is a chronic disease that affects patients quality of life, hence the need to evaluate the qu...
The aim of this review was to evaluate the methods of pain measurement in controlled clinical trials...
Item does not contain fulltextAIMS AND OBJECTIVES: This paper reports a review of the literature con...
Context: Pain is one of the most devastating symptoms for cancer patients. One‐third of patients who...
Most patients with advanced or metastatic cancer experience pain and despite several guidelines, und...
PURPOSE: Cancer pain is a distressing and complex experience. It is feasible that the systematic col...
The aim of this prospective study was to assess the quality of pain management hospitalized cancer p...
Purpose: Pain is a frequent symptom in cancer patients with substantial impact. Despite the availabi...
Background: Pain is one of the most frequent and deleterious symptoms for patients with advanced can...
Cathy L Carlson School of Nursing, Northern Illinois University, DeKalb, IL, USA Abstract: Inadequa...
Item does not contain fulltextPURPOSE: Pain is a major problem in all cancer stages. Cancer pain gui...
Most patients with advanced or metastatic cancer experience pain and despite several guidelines, und...
The medication assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring qua...
A clinical tool to examine prescribing in cancer pain management may provide a means to help establi...
The medication-assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring the...
Cancer is a chronic disease that affects patients quality of life, hence the need to evaluate the qu...
The aim of this review was to evaluate the methods of pain measurement in controlled clinical trials...
Item does not contain fulltextAIMS AND OBJECTIVES: This paper reports a review of the literature con...
Context: Pain is one of the most devastating symptoms for cancer patients. One‐third of patients who...
Most patients with advanced or metastatic cancer experience pain and despite several guidelines, und...
PURPOSE: Cancer pain is a distressing and complex experience. It is feasible that the systematic col...
The aim of this prospective study was to assess the quality of pain management hospitalized cancer p...
Purpose: Pain is a frequent symptom in cancer patients with substantial impact. Despite the availabi...
Background: Pain is one of the most frequent and deleterious symptoms for patients with advanced can...
Cathy L Carlson School of Nursing, Northern Illinois University, DeKalb, IL, USA Abstract: Inadequa...
Item does not contain fulltextPURPOSE: Pain is a major problem in all cancer stages. Cancer pain gui...
Most patients with advanced or metastatic cancer experience pain and despite several guidelines, und...